A Multi-State Non-Homogeneous Semi-Markov Model with Application to HIV/AIDS Disease Progression

Crossmark

Article Sidebar

Page Numbers: 296-308
Download PDF
Published: Aug 25, 2026
Digital Object Identifier:
Save this to:
Save to Mendeley Download RIS

Article Metrics:
Viewed: 30 times
Downloaded: 29 times
Article can trace at:

Author Fee:
Free Publication Fees for Foreign Researchers (USD 0.00)
Check for article on SINTA:

LYAS Publisher cordially invites qualified professionals to serve as Editors or Reviewers. Your expertise will make an important contribution to maintaining and strengthening the academic quality of our publications. Interested applicants are kindly requested to complete the application form at the following link: Editors & Reviewers

Connected Papers:
Connected Papers


Please feel free to contact us if you need any further information about the submission process or if you have any additional questions.


Authors:
A. U. Kinafa1*, A.A. Kwami2, M. H. Alhajiyel3
Copyright :

Authors retain copyright and grant the journal right of first publication.

Explore Our Journals
Find the journal that best fits your research. If this journal does not match your manuscript’s scope, explore our portfolio below to select a more suitable publication venue.

Main Article Content

A. U. Kinafa
Gombe State University, Nigeria
A.A. Kwami
Gombe State University, Nigeria
M. H. Alhajiyel
Gombe State University, Nigeria

Abstract

HIV/AIDS progression is inherently a multi-state stochastic process in which transitions among immunological states evolve over time and are influenced by therapeutic interventions. Standard homogeneous Markov models cannot adequately capture this temporal heterogeneity, necessitating more flexible stochastic frameworks. This study develops and evaluates a multi-state non-homogeneous semi-Markov model (MNHSMM) for characterizing HIV progression across six clinically defined immunological states and estimating state-specific sojourn-time distributions and transition probabilities as functions of calendar time and treatment status. Longitudinal data from 500 HIV-positive adults followed for a median of 84 months were analyzed. The proposed six-state MNHSMM incorporated Weibull-distributed sojourn times and time-varying transition kernels parameterized using B-spline functions, with parameters estimated through maximum likelihood estimation. Model performance was compared with that of homogeneous Markov and homogeneous semi-Markov models using the Akaike information criterion (AIC), Bayesian information criterion (BIC), and likelihood-ratio tests. The MNHSMM achieved the lowest AIC (3281.4) and BIC (3402.6) and significantly outperformed the homogeneous semi-Markov model, χ²(16) = 174.2, p < .001. The mean sojourn time in the asymptomatic state was 28.4 months (95% CI [25.1, 31.7]). Patients receiving antiretroviral therapy exhibited significantly longer sojourn times across all nonabsorbing states and a 37% lower probability of transitioning to death within five years. These findings establish the MNHSMM as a statistically superior and clinically informative framework for modeling HIV progression. Its temporal flexibility can improve long-term survival prediction, support the identification of optimal antiretroviral therapy intervention windows, and inform healthcare planning in sub-Saharan Africa and beyond.

Keywords:
Download Full-Text PDF Direct PDF file • 9909.pdf
Share Article:

Citation Metrics:

Scopus

Downloads

Download data is not yet available.

Citation Metrics & Similar Scopus Articles

Data source Crossref
0
citations
Citation counts are source-specific and may differ because database coverage, reference matching, and update schedules are different. Counts are not added together. Crossref values represent citation links registered and matched by Crossref.
Check Secondary Documents in Scopus
Open this article in Scopus, then check the Secondary documents tab. Use Manual Citation Fallback only for counts you have verified manually.
Open in Scopus
Similar Scopus Articles
Scopus
  1. Wang J. (2027)
    Analysis and Applications of Neuromorphic Memristors in Artificial Intelligence Computing
    Nano Micro Letters, 19(1)
  2. Feng X. (2027)
    Designing Efficient Inverted Perovskite Solar Cells with Self-Assembled Monolayer Hole Transport Layers
    Nano Micro Letters, 19(1)
  3. Zhang X. (2027)
    Rational Design of Covalent Organic Frameworks for Oxygen Electrocatalysis: Recent Advances and Mechanistic Insights
    Nano Micro Letters, 19(1)

Article Details

How to Cite
Kinafa, A. U., Kwami, A., & Alhajiyel, M. H. (2026). A Multi-State Non-Homogeneous Semi-Markov Model with Application to HIV/AIDS Disease Progression. Mikailalsys Journal of Advanced Engineering International, 3(3), 296-308. https://doi.org/10.58578/mjaei.v3i3.9909

Creative Commons License
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

References

Barbu, V. S., & Limnios, N. (2008). Semi-Markov chains and hidden semi-Markov models: Toward applications. Springer. https://doi.org/10.1007/978-0-387-73173-5

Davidov, O., & Zelen, M. (2000). Designing cancer prevention trials: A stochastic model approach. Statistics in Medicine, 19(15), 1983–1995. https://doi.org/10.1002/1097-0258(20000815)19:15%3C1983::AID-SIM534%3E3.0.CO;2-E

de Boor, C. (2001). A practical guide to splines (Rev. ed.). Springer. https://doi.org/10.1007/978-1-4612-6333-3

Efron, B., & Tibshirani, R. J. (1993). An introduction to the bootstrap. Chapman & Hall. https://doi.org/10.1007/978-1-4899-4541-9

Foucher, Y., Mathieu, E., Saint-Pierre, P., Durand, J. F., & Daurès, J. P. (2005). A semi-Markov model based on a generalised Weibull distribution with an illustration for HIV disease. Biometrical Journal, 47(6), 825–833. https://doi.org/10.1002/bimj.200410149

Gentleman, R. C., Lawless, J. F., Lindsey, J. C., & Yan, P. (1994). Multi-state Markov models for analysing incomplete disease history data with illustrations for HIV disease. Statistics in Medicine, 13(8), 805–821. https://doi.org/10.1002/sim.4780130803

Hontelez, J. A. C., de Vlas, S. J., Baltussen, R., Newell, M.-L., Bakker, R., Tanser, F., Lurie, M. N., & Bärnighausen, T. (2012). The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa. AIDS, 26(Suppl. 1), S19–S30. https://doi.org/10.1097/QAD.0b013e3283558526

Howard, R. A. (1971). Dynamic probabilistic systems: Vol. 2. Semi-Markov and decision processes. Wiley.

Janssen, J., & Manca, R. (2006). Applied semi-Markov processes. Springer. https://doi.org/10.1007/0-387-29548-8

Kahn, J. G., Garnett, G. P., Leung, B., & Sacks, H. S. (1992). The costs and benefits of antiretroviral therapy in AIDS: A model-based analysis. AIDS, 6(2), 145–151. https://doi.org/10.1097/00002030-199202000-00004

Limnios, N., & Oprişan, G. (2001). Semi-Markov processes and reliability. Birkhäuser. https://doi.org/10.1007/978-1-4612-0161-8

Longini, I. M., Jr., Clark, W. S., Byers, R. H., Ward, J. W., Darrow, W. W., Lemp, G. F., & Hethcote, H. W. (1989). Statistical analysis of the stages of HIV infection using a Markov model. Statistics in Medicine, 8(7), 831–843. https://doi.org/10.1002/sim.4780080708

Meira-Machado, L., de Uña-Álvarez, J., Cadarso-Suárez, C., & Andersen, P. K. (2009). Multi-state models for the analysis of time-to-event data. Statistical Methods in Medical Research, 18(2), 195–222. https://doi.org/10.1177/0962280208092301

Mellors, J. W., Muñoz, A., Giorgi, J. V., Margolick, J. B., Tassoni, C. J., Gupta, P., Kingsley, L. A., Todd, J. A., Saah, A. J., Detels, R., Phair, J. P., & Rinaldo, C. R., Jr. (1997). Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Annals of Internal Medicine, 126(12), 946–954. https://doi.org/10.7326/0003-4819-126-12-199706150-00003

Nakagawa, F., Lodwick, R. K., Smith, C. J., Smith, R., Cambiano, V., Lundgren, J. D., Delpech, V., & Phillips, A. N. (2012). Projected life expectancy of people with HIV according to timing of diagnosis. AIDS, 26(3), 335–343. https://doi.org/10.1097/QAD.0b013e32834dcec9

Norris, J. R. (1997). Markov chains. Cambridge University Press. https://doi.org/10.1017/CBO9780511810633

Pérez-Ocón, R., Ruiz-Castro, J. E., & Gámiz-Pérez, M. L. (2001). Non-homogeneous Markov models in the analysis of survival after breast cancer. Journal of the Royal Statistical Society: Series C (Applied Statistics), 50(1), 111–124. https://doi.org/10.1111/1467-9876.00223

Stover, J., Glaubius, R., Mofenson, L., Dugdale, C. M., Davies, M.-A., Patten, G., & Yiannoutsos, C. (2019). Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels. AIDS, 33(Suppl. 3), S227–S234. https://doi.org/10.1097/QAD.0000000000002357

Titman, A. C., & Sharples, L. D. (2008). A general goodness-of-fit test for Markov and hidden Markov models. Statistics in Medicine, 27(12), 2177–2195. https://doi.org/10.1002/sim.3033

Titman, A. C., & Sharples, L. D. (2010). Semi-Markov models with phase-type sojourn distributions. Biometrics, 66(3), 742–752. https://doi.org/10.1111/j.1541-0420.2009.01339.x

Touloumi, G., Pantazis, N., Antoniou, A., Stirnadel, H. A., Walker, S. A., Porter, K., & CASCADE Collaboration. (2006). Highly active antiretroviral therapy interruption: Predictors and virological and immunological consequences. Journal of Acquired Immune Deficiency Syndromes, 42(5), 554–561. https://doi.org/10.1097/01.qai.0000230321.85911.db

UNAIDS. (2023). Global HIV & AIDS statistics—Fact sheet. https://www.unaids.org/en/resources/fact-sheet

Wood, S. N. (2017). Generalized additive models: An introduction with R (2nd ed.). Chapman & Hall/CRC. https://doi.org/10.1201/9781315370279

World Health Organization. (2016). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection (2nd ed.). https://www.who.int/publications/i/item/9789241549684